Zhi Jie Li - Concepedia

Author

Zhi Jie Li

Chinese University of Hong Kong

Also Known As

Zhi Jie Li

Publications

990

Citations

H-Index

Concepts

All Affiliations

Chinese University of Hong Kong University of Hong Kong Queen Mary Hospital Southern Medical University Zhejiang University

About

Zhi Jie Li is an author at Chinese University of Hong Kong specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	503
2	Cell Biology	5	5	252
3	Engineering	2	2	85
4	Biomedical Engineering	1	1	74
5	Cellular Physiology	1	1	10

Zhi Jie Li

Publications

757

Citations

H-Index

Page 1

	Year	Citations
Inhibition of macroautophagy by bafilomycin A1 lowers proliferation and induces apoptosis in colon cancer cells Ya Chun Wu, William Ka Kei Wu, Youming Li, Biochemical and Biophysical Research Communications Bafilomycin A1Chemoprevention StrategyMedicineColon Cancer CellsApoptosis	2009	112
The host defense peptide LL‐37 activates the tumor‐suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells William Ka Kei Wu, Joseph J.�Y. Sung, Ka‐Fai To, Journal of Cellular Physiology Gastric Cancer CellsImmunologyPathologyCell DeathCancer Biology	2010	97
Liuwei Dihuang pill treats diabetic nephropathy in rats by inhibiting of TGF-β/SMADS, MAPK, and NF-kB and upregulating expression of cytoglobin in renal tissues Zhong Ju Xu, Shi Shu, Zhi Jie Li, Medicine	2017	88
Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells William Ka Kei Wu, Ya Chun Wu, Le Yu, Biochemical and Biophysical Research Communications Cancer ResearchMitophagyCell AutophagyMedicineColon Cancer Cells	2008	82
A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery Zhi Jie Li, William Ka Kei Wu, Simon S.M. Ng, Journal of Controlled Release NanomedicineEngineeringPeptide EngineeringPeptide LibraryMolecular Imaging	2010	74
2,3′,4,4′,5′‐Pentamethoxy‐<i>trans</i>‐stilbene, a resveratrol derivative, inhibits colitis‐associated colorectal carcinogenesis in mice Haitao Li, William Ka Kei Wu, Zhi Jie Li, British Journal of Pharmacology	2010	58
Macroautophagy and ERK phosphorylation counteract the anti-proliferative effect of proteasome inhibitor in gastric cancer cells William Ka Kei Wu, Chi Hin Cho, Chung Wa Lee, Autophagy	2010	45
2,3′,4,4′,5′-Pentamethoxy-trans-stilbene, a resveratrol derivative, is a potent inducer of apoptosis in colon cancer cells via targeting microtubules Haitao Li, William Ka Kei Wu, Zong‐Ping Zheng, Biochemical Pharmacology Drug TargetingChemoprevention StrategyMedicineColon Cancer CellsApoptosis	2009	40
Vascular-targeted TNFα improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer Lan Lu, Zhi Jie Li, Long Fei Li, Journal of Controlled Release Tumor BiologyCancer ImmunosurveillanceOncologyMedicineImmunology	2015	33
3,3′,4,5,5′-pentahydroxy-trans-stilbene, a resveratrol derivative, induces apoptosis in colorectal carcinoma cells via oxidative stress Haitao Li, William Ka Kei Wu, Zong‐Ping Zheng, European Journal of Pharmacology Redox SignalingCancer ResearchMedicinal ChemistryColorectal Carcinoma CellsChemoprevention Strategy	2010	32

Page 1